Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.
Clinical trial NCT00238849 · UNKNOWN
Trial details
- NCT number
- NCT00238849
- Sponsor
- Integrated Community Oncology Network
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.